| Literature DB >> 30305267 |
Innocent Safeukui1,2,3,4, Pierre A Buffet5,6, Guillaume Deplaine1,2,5, Sylvie Perrot1,2, Valentine Brousse7, Alain Sauvanet8, Beatrice Aussilhou8, Safi Dokmak8, Anne Couvelard9, Dominique Cazals-Hatem9, Odile Mercereau-Puijalon1,2, Geneviève Milon10, Peter H David1,2, Narla Mohandas11.
Abstract
The current paradigm in the pathogenesis of several hemolytic red blood cell disorders is that reduced cellular deformability is a key determinant of splenic sequestration of affected red cells. Three distinct features regulate cellular deformability: membrane deformability, surface area-to-volume ratio (cell sphericity), and cytoplasmic viscosity. By perfusing normal human spleens ex vivo, we had previously showed that red cells with increased sphericity are rapidly sequestered by the spleen. Here, we assessed the retention kinetics of red cells with decreased membrane deformability but without marked shape changes. A controlled decrease in membrane deformability (increased membrane rigidity) was induced by treating normal red cells with increasing concentrations of diamide. Following perfusion, diamide-treated red blood cells (RBCs) were rapidly retained in the spleen with a mean clearance half-time of 5.9 minutes (range, 4.0-13.0). Splenic clearance correlated positively with increased membrane rigidity (r = 0.93; P < .0001). To determine to what extent this increased retention was related to mechanical blockade in the spleen, diamide-treated red cells were filtered through microsphere layers that mimic the mechanical sensing of red cells by the spleen. Diamide-treated red cells were retained in the microsphilters (median, 7.5%; range, 0%-38.6%), although to a lesser extent compared with the spleen (median, 44.1%; range, 7.3%-64.0%; P < .0001). Taken together, these results have implications for understanding the sensitivity of the human spleen to sequester red cells with altered cellular deformability due to various cellular alterations and for explaining clinical heterogeneity of RBC membrane disorders.Entities:
Mesh:
Year: 2018 PMID: 30305267 PMCID: PMC6199658 DOI: 10.1182/bloodadvances.2018024562
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529